Journal of Heterocyclic Chemistry p. 229 - 239 (2000)
Update date:2022-08-05
Topics:
Grozinger, Karl G.
Byrne, Denis P.
Nummy, Laurence J.
Ridges, Michael D.
Salvagno, Annette
Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.
View MoreContact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
Contact:+86-570-4336358
Address:No.87 Building,Tianqian,Sidu Town
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Doi:10.1016/j.tet.2017.02.061
(2017)Doi:10.1016/S0040-4020(03)00770-1
(2003)Doi:10.1039/b000600i
(2000)Doi:10.1016/j.catcom.2010.02.007
(2010)Doi:10.1039/b807704e
(2008)Doi:10.1002/1521-3765(20010601)7:11<2332::AID-CHEM23320>3.0.CO;2-W
(2001)
